In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 167 for your search:
Drug:  pegylated liposomal doxorubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: GEICAM 2001-01, NCT00128778

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 75 and over
Sponsor: Other
Protocol IDs: CDR0000593133, GERCOR-OLD, EudraCT-2007004103-36, GERCOR-OLD07-SA07-1, NCT00664911

3.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GBG 66, 2011-000553-23, NCT01426880

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: DS 96-28, RPCI-DS-96-28, SEQUUS-30-38, NCI-G97-1241, NCT00002985

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SEQUUS-30-49, NCI-V97-1257

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: GOG-0182, NCI-2012-02376, SWOG-G0182, CDR0000068467, ISRCTN41636183, MRC-ICON5, ECOG-G0182, U10CA027469, NCT00011986

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004579, DO04-23-006, NCT00097981

8.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TLK286.3024, NCT00102973

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004117, DOXILMMY3001, 2004-001842-34, NCT00103506

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR003448, ET743-OVA-301, 2004-005276-16, NCT00113607

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CALYPSO, EudraCT 2004-04456-39, NCT00189553

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CEPO906A2303, NCT00262990

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor: Other
Protocol IDs: MITO-2, 2005-004453-98, NCT00326456

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004120, DOXILBCA3001, UCLA-0507099-01, JJPRD-DOXIL-BCA-3001, NCT00091442

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000256331, S0200, U10CA032102, SWOG-S0200, NCT00043082

16.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SAKK 92/08, SWS-SAKK-92/08, EU-20978, CDR0000652808, NCT00992706

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03149, E1D96, U10CA021115, CDR0000066331, AMC-009, SWOG-E1D96, CPMC-IRB-9905, NCT00003350

18.

Phase: Phase III
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8109-002, EC-FV-06, NCT01170650

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20060517, 2009-017946-30, ENGOT-ov-6, TRINOVA-2, NCT01281254

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P04445, NCT00266799

21.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065641, P30CA051008, GUMC-96007, VX-95-853-001, VX-GUMC-96007, NCI-V97-1275, NCT00004030

22.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-99054, LIPO-D9905, NCI-G00-1684, NCT00004925

23.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000068042, CLB-59804, CALGB-59804, NCT00006029

24.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068331, P30CA016087, NYU-0012, ALZA-00-001-ii, NCI-G00-1878, NCT00006825

25.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000069262, AGOSG-AGO-GYN-2, EU-20147, NCT00032162
1     
New Search